Mitsuka M, Nagae M, Berk B C
Department of Medicine, Emory University School of Medicine, Atlanta, Ga 30322.
Circ Res. 1993 Aug;73(2):269-75. doi: 10.1161/01.res.73.2.269.
The presence of multiple growth stimuli at the sites of vascular injury following angioplasty suggests that therapies targeted toward common growth pathways will be more effective than therapies that inhibit only a single growth factor. We tested this hypothesis using amiloride and ethyl isopropyl amiloride (EIPA), which are inhibitors of the Na(+)-H+ exchanger, whose activity is required in many cells for proliferation and migration. In the rat carotid injury model, EIPA (100 micrograms/h for 15 days) significantly decreased intimal area and the ratio of intimal to medial area, whereas amiloride (25 micrograms/h) showed an inhibitory trend that was similar to that observed for captopril (80 mg/kg per day) and heparin (25 U/h). EIPA and amiloride inhibited rat vascular smooth muscle cell DNA synthesis, with IC50 values of 8.8 and 82.2 microM, respectively. Using platelet-derived growth factor as a chemoattractant, EIPA caused a concentration-dependent inhibition of migration (IC50, approximately 60 microM). Because amiloride and EIPA have nonspecific effects on cellular function (especially inhibition of tyrosine kinases), we sought to characterize the specific role of the Na(+)-H+ exchanger in vascular smooth muscle cell proliferation and migration. We generated a Na(+)-H+ exchanger-deficient mutant cell line [RNHE(-)]. Studies with these cells suggested that the inhibitory effects of EIPA and amiloride were mediated only in part via Na(+)-H+ exchange because (1) RNHE(-) cells grew well at pH 6.8 to 7.5 in bicarbonate-containing medium, and (2) there was no difference in migration in response to platelet-derived growth factor in the RHNE(-) cells. In summary, these data indicate that amiloride and EIPA inhibit neointimal formation in the rat carotid after injury. However, the mechanism of inhibition is likely to involve cellular events other than Na(+)-H+ exchange, such as an effect on tyrosine kinases.
血管成形术后血管损伤部位存在多种生长刺激因素,这表明针对常见生长途径的治疗方法比仅抑制单一生长因子的治疗方法更有效。我们使用氨氯吡咪和乙基异丙基氨氯吡咪(EIPA)对这一假设进行了验证,它们是钠氢交换体的抑制剂,许多细胞的增殖和迁移都需要该交换体的活性。在大鼠颈动脉损伤模型中,EIPA(100微克/小时,持续15天)显著减小了内膜面积以及内膜与中膜面积之比,而氨氯吡咪(25微克/小时)呈现出与卡托普利(80毫克/千克/天)和肝素(25单位/小时)相似的抑制趋势。EIPA和氨氯吡咪抑制大鼠血管平滑肌细胞DNA合成,IC50值分别为8.8和82.2微摩尔。以血小板衍生生长因子作为趋化剂,EIPA引起浓度依赖性的迁移抑制(IC50约为60微摩尔)。由于氨氯吡咪和EIPA对细胞功能有非特异性作用(尤其是抑制酪氨酸激酶),我们试图确定钠氢交换体在血管平滑肌细胞增殖和迁移中的具体作用。我们构建了一种缺乏钠氢交换体的突变细胞系[RNHE(-)]。对这些细胞的研究表明,EIPA和氨氯吡咪的抑制作用仅部分通过钠氢交换介导,原因如下:(1)RNHE(-)细胞在含碳酸氢盐的培养基中,pH值为6.8至7.5时生长良好;(2)RHNE(-)细胞对血小板衍生生长因子的迁移反应没有差异。总之,这些数据表明氨氯吡咪和EIPA可抑制大鼠颈动脉损伤后的新生内膜形成。然而,抑制机制可能涉及钠氢交换以外的细胞事件,如对酪氨酸激酶的影响。